SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OSTEOTECH (OSTE)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Johnnie W. who wrote (29)9/11/1997 1:15:00 AM
From: Elvis Jones   of 141
 
Where did you hear about OSTE? I curious to learn who's buying this up, any price targets, anything! I guess it just leaves me wondering (though not complaining).

I have been long OSTE for over a year. Hitting $21 this quickly surprises even me at this point. How high is up? I originally thought 30 times forward earnings (now $0.69). We are easily there. However, I noticed Zacks has listed an estimated 55% five-year annual growth rate. If I buy into the PE vs. Growth Rate argument, am I looking for $35-40/share. I don't have a clue anymore.

This company is beautiful. The Grafton line probably handles any bone transplant needs both easily and effectively. And have over 1 million "cadaver bone" transplants without a confirmed passing of disease (a fear using cadaver bone).

Another stock, a competitor, is Interpore International (BONZ). They are using sea coral as bone substitute. Interesting approach, but I still like OSTE better.

Happily Long OSTE,
Duke

PS. Interesting Occupation you have!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext